Specialist guidance on specific treatment designed to lower blood sugar levels.
A new training programme is available for healthcare professionals to access and gain a better understanding about a specific type 2 diabetes medication.
A new training programme module to help GPs and community nurses know more about glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is now available as an online course.
New Decade, New Therapies: Simplifying the Complex is a CPD-accredited (continuing professional development) course looking at GLP-1 RA treatments has been developed by the Leicester Diabetes Centre in collaboration with Primary Care Diabetes Europe (PCDE).
Researchers at the Leicester Diabetes Centre said the course could vastly improve health outcomes for people with type 2 diabetes.
This class of drug is very effective at lowering blood sugar levels and has also been found to improve heart health and kidney function. However, some people may be better suited to treatment with GLP-1 RAs than others.
The first module launched in March (as reported here), and further sessions will feature webcast discussions between top diabetes researchers Professor Melanie Davies CBE, Professor Kamlesh Khunti and Dr Samuel Seidu.
They will discuss the practical aspects of initiation and titrations of GLP-1RA and their combinations with other glucose lowering therapies.
Almost one in three of all deaths from coronavirus among people in hospital in England during the Covid-19 pandemic have been associated with diabetes and healthcare professionals said it was more important than ever for people with diabetes to receive the best care possible.
Leicester Diabetes Centre Professors Melanie Davies CBE and Kamlesh Khunti
Professor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and also Co-Director of the Leicester Diabetes Centre, said: “Covid-19 is very new to all of us and seems to be affecting people with diabetes much more disproportionately and also appears to lead to worse outcomes, so it’s vital we ensure all our patients are as healthy as they can be. This module will cover the key aspects from the latest evidence on GLP-1 RA treatments.”
Professor Davies, Professor of Diabetes Medicine at the University of Leicester and Co-Director of the Leicester Diabetes Centre at Leicester General Hospital, said: “This module will provide primary care staff with a helping hand so they can treat people with type 2 diabetes more effectively.
“Patient-centred care has never been so important and because of the rapid availability of new therapies in this area, and the opportunities to combine them in more innovative ways, it is really important that primary care teams are supported and understand how they can optimise the opportunities offered with the availability of GLP-1 RA’s.”
This module is just one of a number of resources for healthcare professionals and patients to support those with diabetes remotely during the Covid-19 pandemic
Others include the free release of the MyDesmond app, an interactive education and support programme for people with type 2 diabetes. In October the third and final module will be available and this covers innovations in GLP-1RAs. There will also be accompanying presentation resources to further support the learning throughout the course.
Healthcare professionals can register for the online training course here
More information about the MyDesmond course
Find out more about type 2 diabetes
Support DRWF by making a donation here
Find out more about DRWF-funded research here
DRWF operations during the Covid-19 health crisis
The DRWF team is now working remotely. Covid-19 guidance, particularly where it aligns or impacts with diabetes guidance, is shared as quickly as possible through the DRWF website and social media channels with the aim of making it as easy to understand as possible and a reliable source of latest news.
To receive the charity’s latest bulletins as they become available, please sign up here
Subscribe to Diabetes Wellness News here